BSEBoard Meeting29 Sept 2026 · 29 Sept 2026, 04:22 pm
Outcome of the board meeting for the board approves the Preferential Allotment
Bharat Parenterals Ltd · 541096
✦ AI SummaryFundraise
Bharat Parenterals Ltd has announced the outcome of its board meeting, where it approved the preferential allotment of up to 9,12,759 equity shares at Rs. 1522.85 per share for an aggregate consideration of Rs. 138,99,95,043.15. The company will convene an EGM on October 23, 2026, to seek shareholder approval for the preferential issue.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk4/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Bharat Parenterals Ltd - 541096 - Board Meeting Outcome for Outcome Of Board Meeting For The Board Approves The Preferential Issue.
Attachments (1)
📄pdf
Download →
f6d9abb7-7050-4b1a-9725-aa4ea17421fb.pdf
View document text
Date: September 29, 2026
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street, Fort,
Mumbai –400001
Scrip Code: 541096
Sub: Outcome of Board Meeting – Board approves preferential allotment
Ref: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (“Listing Regulations”)
We wish to inform you that the Board of Directors of the Company at their meeting held today,
have inter alia considered and approved the following:
1. Issuance of up to 9,12,759 (Nine Lakhs Twelve Thousand Seven Hundred and Fifty-Nine
Only) equity shares of face value Rs. 10/- each fully paid up of the Company, through
preferential allotment, in compliance with applicable provisions of the Companies Act,
2013 and Chapter V of SEBI (Issue of Capital and Disclosure Requirements) Regulations,
2018, at a price of Rs. 1522.85 (One Thousand Five Hundred Twenty-Two Rupees and
Eighty-Five Paise Only) per equity share for an aggregate consideration of Rs.
138,99,95,043.15/- (One Hundred Thirty-Eight Crore Ninety-Nine Lakh Ninety-Five
Thousand Forty-Three Rupees and Fifteen Paisa Only), to few Investors (Non-Promoters),
as detailed in Annexure 1A, for cash consideration, subject to the approval of the
shareholders of the Company and other regulatory/statutory approvals as applicable.
Additional details pursuant to Regulation 30 of the Listing Regulations is attached as
Annexure-1.
2. Investment in Subsidiaries – For undertaking investments in or providing loans to the
subsidiaries of the Company for the purposes of development of existing and new
projects, either in the form of equity / quasi equity / unsecured loan:
3. Convening of an Extraordinary general meeting on Friday, October 23, 2026 at 11:30 A.M
through video conferencing or other audio-visual means, to seek necessary approval of
the shareholders of the Company, for the Preferential Issue.
The meeting of the Board of Directors commenced at 03:00 P.M. at the registered office and
concluded at 04:00 P.M.
This is for your information and records.
Thanking You.
For Bharat Parenterals Limited
Sharmin Soni
Company Secretary & Compliance Officer
ICSI Membership Number: A-75694
Encls. As above
Annexure-1
Additional details as required under Regulation 30 and other relevant provisions of the
Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements)
Regulations, 2015
Issuance of Equity Shares under Preferential Allotment
Sr. Particulars Remarks
a) Type of Securities proposed to be Equity Shares of Face value of Rs. 10/- each of
issued (viz., equity shares, the Company
convertibles etc.)
b) Type of Issuance Preferential Allotment for cash consideration
(viz., further public offering, rights
issue, depository receipts
(ADR/GDR), qualified institutions
placement, preferential allotment
etc.)
c) Total number of securities proposed 9,12,759 Equity Shares of Rs. 10/- each at an
to be issued or issue price of Rs.1522.85/- per equity share, for
an aggregate consideration of Rs.
the total amount for which the 138,99,95,043.15/- (One Hundred Thirty-Eight
securities will be issued Crore Ninety-Nine Lakh Ninety-Five Thousand
(approximately) Forty-Three Rupees and Paisa Fifteen Only)
d) In case of preferential issue, the listed entity shall disclose the following
additional details to the stock exchange(s):
ii. Names of the Investors
(ii.a) Post allotment of securities, outcome Attached as Annexure 1A
of the subscription, issue/allotted
price 15 (Fifteen)
(ii.b) Number of investors
(iii) in case of convertibles: Not Applicable
intimation on conversion of securities
or on lapse of the tenure of the
instrument
Annexure 1A
Name of Investors, Post allotment of securities, outcome of the subscription, issue/allotted
price
No. of
equity
Sr. Name of proposed shares Pre -issue Post-issue
Category
No. allottee proposed shareholding shareholding
to be
allotted
No. of No. of
shares shares
WHITEOAK
CAPITAL INDIA
1 AIF 0 3,02,065 3.87
OPPORTUNITIES 3,02,065 0
FUND
AURUM RISING
2 AIF 0 0 1,64,165 2.10
INDIA FUND 1,64,165
WHITEOAK
CAPITAL EQUITY
TRUST - 1,31,332
3 AIF 0 0 1,31,332 1.68
WHITEOAK
CAPITAL EQUITY
FUND II
ASHOK INDIA
EQUITY
4 FPI 0 0 80,631 1.03
INVESTMENT 80,631
TRUST PLC
WHITEOAK
Mutual
5 CAPITAL MULTI 45,966 0 0 45,966 0.59
Fund
CAP FUND
INDIA ACORN 37,127
6 FPI 0 0 37,127 0.48
FUND LTD
PERPETUITY
HEALTH TO 36,116
7 AIF 27000 0.392 63,116 0.81
WEALTH (H2W)
RISING FUND
WHITEOAK
8 CAPITAL EQUITY AIF 26,266 0 0 26,266 0.34
FUND
SOAR WEALTH 19,699
9 LLP 0 0 19,699 0.25
MANAGERS LLP
SNEHAL
BHUPENDRA SHAH
10 JOINT WITH Individual 19,699 679 0.010 20,378 0.26
SURABHI SNEHAL
SHAH
ASHOKA
WHITEOAK
11 EMERGING FPI 13,579 0 0 13,579 0.17
MARKETS TRUST
WHITEAOK
CAPITAL PHARMA Mutual
12 5045 0.070 18,178 0.23
AND HEALTHCARE Fund 13,133
FUND
13 KISHORE MUNDRA Individual 9,849 0 0 9,849 0.13
NITIN JAIN, 6,566
14 DYMPAL NITIN Individual 0 0 6,566 0.08
JAIN
WHITEOAK 6,566
CAPITAL Mutual
15 0 0 6,566 0.08
AGGRESSIVE Fund
HYBRIDE FUND
Total 9,12,759 32,724 0.472 9,45,483 12.11